当前位置:首页 - 行情中心 - 佰仁医疗(688198) - 财务分析 - 现金流量表

佰仁医疗

(688198)

  

流通市值:129.70亿  总市值:129.70亿
流通股本:1.38亿   总股本:1.38亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金168,673,464.87643,576,394.11428,045,257.95307,477,775.9
  收到其他与经营活动有关的现金3,131,383.3728,545,681.9125,066,359.9323,469,946.87
  经营活动现金流入小计171,804,848.24672,122,076.02453,111,617.88330,947,722.77
  购买商品、接受劳务支付的现金9,365,171.5540,855,610.6931,046,209.5124,930,139.07
  支付给职工以及为职工支付的现金59,648,996.32172,686,800.21122,207,975.9985,382,662.4
  支付的各项税费52,809,070.2474,862,543.0357,253,128.3453,694,159.3
  支付其他与经营活动有关的现金38,537,332.4185,924,092.42142,717,360.3791,657,417.57
  经营活动现金流出小计160,360,570.51474,329,046.35353,224,674.21255,664,378.34
  经营活动产生的现金流量净额11,444,277.73197,793,029.6799,886,943.6775,283,344.43
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,050,912.3211,034,164.6610,921,895.262,044,049.05
  处置固定资产、无形资产和其他长期资产收回的现金净额20,0001,024.171,026.291,028.03
  收到的其他与投资活动有关的现金328,726,079.05943,000,000821,200,000536,400,000
  投资活动现金流入小计329,796,991.37954,035,188.83832,122,921.55538,445,077.08
  购建固定资产、无形资产和其他长期资产支付的现金38,203,786.99136,196,463.77103,960,911.488,933,082.34
  投资支付的现金15,000,00018,000,000--
  支付其他与投资活动有关的现金221,059,669.54978,600,001831,800,000429,300,000
  投资活动现金流出小计274,263,456.531,132,796,464.77935,760,911.4518,233,082.34
  投资活动产生的现金流量净额55,533,534.84-178,761,275.94-103,637,989.8520,211,994.74
三、筹资活动产生的现金流量:
  吸收投资收到的现金-5,333,603.355,333,603.35-
  取得借款收到的现金-75,000,00075,000,00065,000,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-80,333,603.3580,333,603.3565,000,000
  偿还债务支付的现金25,000,000---
  分配股利、利润或偿付利息支付的现金537,473.55110,837,760.05110,433,947.55110,075,497.56
  支付其他与筹资活动有关的现金263,948.744,675,208.962,958,979.572,308,344.09
  筹资活动现金流出小计25,801,422.29115,512,969.01113,392,927.12112,383,841.65
  筹资活动产生的现金流量净额-25,801,422.29-35,179,365.66-33,059,323.77-47,383,841.65
四、汇率变动对现金及现金等价物的影响-49,856.45-142,375.25-114,344.48-4,963.34
五、现金及现金等价物净增加额41,126,533.83-16,289,987.18-36,924,714.4348,106,534.18
  加:期初现金及现金等价物余额39,259,820.0755,549,807.2555,549,807.2555,549,807.25
  期末现金及现金等价物余额80,386,353.939,259,820.0718,625,092.82103,656,341.43
补充资料:
  净利润-179,682,344.8-65,459,399.49
  固定资产和投资性房地产折旧-27,884,353.98-12,984,603.12
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-27,884,353.98-12,984,603.12
  无形资产摊销-10,252,265.75-3,813,606.53
  长期待摊费用摊销-3,555,588.95-2,132,987.28
  处置固定资产、无形资产和其他长期资产的损失--1,765.08--1,753.37
  固定资产报废损失-3,729--
  公允价值变动损失--830,305.47--8,921.33
  财务费用--85,430.92-643,274.2
  投资损失--7,845,299.96--4,838,321.34
  递延所得税--2,531,848.94--2,712,112.86
  其中:递延所得税资产减少--2,566,656.09--2,263,126.91
    递延所得税负债增加-34,807.15--448,985.95
  存货的减少--15,883,478.36--16,468,643.8
  经营性应收项目的减少--75,270,181.59-3,546,911.69
  经营性应付项目的增加-72,151,758.02-9,525,920.39
  不涉及现金收支的投资和筹资活动金额其他项目-13,147,557.44--
  现金的期末余额-39,259,820.07-103,656,341.43
  减:现金的期初余额-55,549,807.25-55,549,807.25
  现金及现金等价物的净增加额--16,289,987.18-48,106,534.18
公告日期2026-04-222026-04-222025-10-312025-08-28
审计意见(境内)标准无保留意见
TOP↑